Updates and news related to prostate cancer:
Breakthrough discovery to transform prostate cancer treatment
A novel formulation of prostate cancer drug will improve quality of life.
COVID-19, prostate cancer, and Us TOO
Us Too has created a webpage dedicated to addressing the impact of the pandemic on those affected by prostate cancer.
UCLA researchers find cryotherapy as an effective treatment for men with intermediate-risk prostate cancer
A news release from UCLA Health
Paths to Health: Tools for healthier living
Participate in virtual programs such as "Better Choices, Better Health," "Chronic Disease Self-Management," and more
Laser-targeted removal of prostate tumor works as well as complete removal of prostate
Laser treatment, however, preserves erectile and urinary functions.
Time to reassess active surveillance risks in prostate cancer?
An article from Us TOO International's June Hot Sheet
Patients of metastatic prostate cancer could benefit from immunotherapy treatment
A Cancer Network article detailing a study published in Science Translational Medicine
Erleada for non-metastatic, castration resistant prostate cancer
Learn how Erleada compares with other medications, its uses and side effects
Radiotherapy for prostate cancer adjusted during COVID-19
An article on the management of radiotherapy during a pandemic
Study demonstrates promise for Olaparib in metastatic-castrate resistant prostate cancer
Read this Cancer Network article by Hannah Slater